No Data
No Data
Express News | Precision BioSciences Receives Approval in Hong Kong to Expand Pbgene-Hbv Phase 1 Eliminate-B Trial for the Treatment of Chronic Hepatitis B
Gene Editing Market Forecast Report 2024, With Profiles of Merck, GenScript, Revvity, Lonza, Precision BioSciences, Cellectis, AMSBIO, Synthego, Takara Bio, Bio-Techne, Reprocell and More
Precision BioSciences to Participate in Upcoming November Investor Conferences
Express News | Precision BioSciences Inc - Global Study Recruiting Patients, U.S. Ind Expected in 2025
Express News | Precision BioSciences Inc - Phase 1 Trial Eliminate-B to Assess Safety and Efficacy
Express News | Precision BioSciences Highlights Preclinical Data and Outlines Design of First-in-Human Clinical Trial for Pbgene-Hbv for Treatment of Chronic Hepatitis B
Unlock the Full List